252 Participants Needed

Imaging Techniques for Intracranial Hemorrhage

(SPINNERS Trial)

Recruiting at 13 trial locations
MP
AB
Overseen ByAlex Brehm, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University Hospital, Basel, Switzerland
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Non-contrast cranial MDCT head scan and related imaging techniques for intracranial hemorrhage?

Research shows that advanced imaging techniques like Syngo DynaCT and Sine Spin FDCT improve image quality by reducing artifacts, which can help in better diagnosing and managing brain conditions. These techniques have been effective in detecting complications during neuroendovascular procedures, suggesting they could be useful for identifying intracranial hemorrhages.12345

Is the imaging technique for intracranial hemorrhage safe for humans?

The studies reviewed do not specifically address safety concerns, but they focus on improving image quality and diagnostic performance, suggesting that the imaging techniques are generally considered safe for use in humans.12345

How does the Non-contrast syngo DynaCT Sine Spin head scan treatment differ from other treatments for intracranial hemorrhage?

The Non-contrast syngo DynaCT Sine Spin head scan is unique because it uses a flat detector CT (FDCT) with a double oblique trajectory to reduce image artifacts and improve soft tissue imaging, offering better image quality compared to traditional CT scans. This advanced imaging technique allows for clearer visualization of the brain, which can be crucial in diagnosing and managing intracranial hemorrhage.12346

What is the purpose of this trial?

Stroke is one of the leading causes of mortality and disability worldwide. Optimization of intra-hospital pathways is as of today one of the most promising research topics in stroke treatment. A potential solution to shorten the time needed for current workflows, and therefore reperfusion, is to do both imaging and subsequent endovascular therapy (EVT) in the angiography suite using non-contrast syngo DynaCT Sine Spin (FDCT) for the exclusion of intracranial hemorrhage and flat detector CT angiography (FDCTA) or digital subtraction angiography for diagnosis of LVO. It is still a matter of debate if FDCT can reliably differentiate between ischemic and hemorrhagic stroke.This study aims to investigate if non-contrast syngo DynaCT Sine Spin imaging is non-inferior to non-contrast MDCT imaging regarding its sensitivity and specificity for the detection of intracranial hemorrhages.

Research Team

MP

Marios-Nikos Psychogios, Prof Dr

Principal Investigator

University Hospital, Basel, Switzerland

AS

Adam S Arthur, MD, MPH

Principal Investigator

Semmes Murphey Clinic and University of Tennessee Health Sciences Center

Eligibility Criteria

This trial is for adults over 18 with symptoms of a stroke, who can give informed consent and arrive at the hospital within 24 hours of their last known well time. They should be able to have two types of head scans within four hours. It's not suitable for those who don't meet these timing or consent requirements.

Inclusion Criteria

I sought medical help within 24 hours of feeling unwell.
I am older than 18 years.
Your doctor needs to agree to perform a specific type of imaging test called non-contrast syngo DynaCT Sine Spin.
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 day
1 visit (in-person)

Imaging

Participants undergo a non-contrast MDCT scan followed by a non-contrast syngo DynaCT Sine Spin head scan

Within 4 hours
1 visit (in-person)

Follow-up

Participants are monitored for adverse device events and the occurrence of intracranial hemorrhages

24 hours
1 visit (in-person)

Treatment Details

Interventions

  • Non-contrast cranial MDCT head scan
  • Non-contrast syngo DynaCT Sine Spin head scan and application software
Trial Overview The study tests if a new type of non-contrast head scan called syngo DynaCT Sine Spin is as good as the standard non-contrast MDCT scan in detecting bleeding inside the skull after a stroke.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Cranial non-contrast syngo DynaCT Sine Spin scanExperimental Treatment2 Interventions
There is only one arm as all patients undergo the same intervention. Subjects with clinical features/symptoms of a stroke (hemorrhagic and non-hemorrhagic stroke patients) will be enrolled. All patients will undergo first a non-contrast MDCT scan and then a non-contrast syngo DynaCT Sine Spin head scan within a maximum timespan of 4 hours between both scans. Only patients in which no invasive procedure in between is planned can be enrolled.

Non-contrast syngo DynaCT Sine Spin head scan and application software is already approved in European Union, United States for the following indications:

๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Syngo Dyna CT imaging for:
  • Detection of intracranial hemorrhage
๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Syngo Dyna CT imaging for:
  • Detection of intracranial hemorrhage

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Hospital, Basel, Switzerland

Lead Sponsor

Trials
1,031
Recruited
2,503,000+

Siemens Healthineers AG

Collaborator

Trials
3
Recruited
2,500+

Findings from Research

The advanced reconstruction algorithm (syngo DynaCT Head Clear) significantly improves image quality in flat detector CT scans of the brain, reducing cone beam artifacts that typically affect peripheral areas.
In a study involving 11 volumetric datasets, observers rated images reconstructed with the advanced algorithm as having better quality compared to standard methods, with statistically significant improvements noted in both supraganglionic and infratentorial regions.
A novel reconstruction tool (syngo DynaCT Head Clear) in the post-processing of DynaCT images to reduce artefacts and improve image quality.Lescher, S., Reh, C., Hoelter, MC., et al.[2019]
The Sine Spin FDCT (SFDCT) protocol demonstrated high sensitivity (up to 84.2%) and specificity (up to 100%) for detecting various types of intracranial hemorrhages and early ischemic lesions, making it a reliable imaging option in the angiography suite.
While SFDCT showed a lower effective dose of 2 mSv compared to previous protocols, it had limitations in image quality, particularly in differentiating grey-white matter and visualizing infratentorial structures.
Evaluation of Sine Spin flat detector CT imaging compared with multidetector CT.Petroulia, VD., Kaesmacher, J., Piechowiak, EI., et al.[2023]
The use of advanced DSA techniques, such as Syngo-Dyna CT and three-dimensional DSA iPilot, enhances the treatment of intracranial aneurysms by providing improved imaging during procedures.
Merging MR and Dyna-CT images post-procedure offers a quick and effective way to verify the success of the intervention, highlighting the potential for better patient outcomes.
Advanced digital subtraction angiography and MR fusion imaging protocol applied to accurate placement of flow diverter device.Faragรฒ, G., Caldiera, V., Tempra, G., et al.[2016]

References

A novel reconstruction tool (syngo DynaCT Head Clear) in the post-processing of DynaCT images to reduce artefacts and improve image quality. [2019]
Evaluation of Sine Spin flat detector CT imaging compared with multidetector CT. [2023]
Advanced digital subtraction angiography and MR fusion imaging protocol applied to accurate placement of flow diverter device. [2016]
Advanced digital subtraction angiography and MR fusion imaging protocol applied to accurate placement of flow diverter device. [2019]
The utility of DynaCT in neuroendovascular procedures. [2021]
[Diagnostic evaluation of the craniocervical vascular system with a 16-slice multi-detector row spiral CT. Protocols and first experiences]. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity